Higher levels of hostility are linked with earlier treatment discontinuation in people with schizoph...
A recent study published in JAMA Psychiatry reports that adults with schizophrenia die at 3.5 times ...
The presence of a genetic polymorphism and the speed with which a patient metabolizes risperidone ma...
Microglial activity—indicative of an immune response to neuroinflammation—appears to be elevated in ...
People with schizophrenia may be at a higher risk for dementia with an earlier age at onset than tho...
The Food and Drug Administration (FDA) last week approved Vraylar (cariprazine), a dopamine D2/D3 re...
Yesterday, the Food and Drug Administration announced that it is making changes to the requirements ...
Although it is well established that patients with schizophrenia have deficits in cortical gray matt...
The ability to firmly diagnose schizophrenia before symptoms of the disease arise can help improve p...
